Monarch Medical Research
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Monarch Medical Research sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Monarch Medical Research: 4 sponsored US clinical trials, none currently recruiting.
Monarch Medical Research sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 2 completed. 2 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Basilar Migraine, with 1 trials.
Upper-quartile sponsor footprint
Monarch Medical Research sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Atomoxetine for Children With Acquired Attentional Disorders Following Completion of Chemotherapy for ALL
NCT00299234
Topiramate for the Prophylactic Treatment of Cyclic Vomiting Syndrome in Children
NCT00286988
Dose Comparison Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine
NCT00131443
A Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine
NCT00158002
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 4 | 2 |
Therapeutic Areas
How the Monarch Medical Research archive is shaped
4 indexed studies, none listed as recruiting (0% open); 2 completed (50%).
Phase mix: 2 late (III/IV) vs 2 early (I/II) (balanced across stages).
Top condition: Basilar Migraine (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Monarch Medical Research: archived-pipeline peers nationwide
Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Monarch Medical Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 archived trials
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Monarch Medical Research page
4 registered trials is a research-attention snapshot, not an endorsement of Monarch Medical Research or any single study.
- None of Monarch Medical Research's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Basilar Migraine is the condition Monarch Medical Research studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Basilar Migraine trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Monarch Medical Research pipeline card: 4 registered trials from official public datasets.Report a data error.